Literature DB >> 22821332

The HLA-Cw*06 allele and -1149 G/T polymorphism of extrapituitary promoter of PRL gene as a possible common genetic predisposing factors to psoriasis vulgaris and psoriatic arthritis in Czech population.

Anna Cibulova1, Marta Zajacova, Marketa Fojtikova, Jiri Stolfa, Liliana Sedova, Pavlina Cejkova, Jan Lippert, Petr Arenberger, Marie Cerna.   

Abstract

Psoriatic arthritis (PsA) affects approximately 30 % of patients suffering from psoriasis vulgaris (PsV), but the risk factors for its development have not been well elucidated yet. The HLA-Cw*06 allele was described as a predisposing factor to PsV. Prolactin is known as an immune response modulator, and its elevated levels present risk for PsV development. It is possible that these factors interact and together emphasize the predisposition to both diseases. We tested on an association of HLA-Cw alleles and functional polymorphism -1149 G/T in PRL gene extrapituitary promoter with PsV and PsA in Czech population. We found a statistically significant association between HLA-Cw*06 allele and PsV (P corrected = 0.0013) that was most prominent in early onset disease subtype (P corrected = 0.0013). The association between HLA-Cw*06 and PsA was low (P corrected = 0.0585) and restricted to PsA patients with early PsV onset (P corrected = 0.0195). We found no association of -1149 G/T PRL gene polymorphism with either PsV or PsA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22821332     DOI: 10.1007/s00296-012-2472-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  42 in total

1.  Distinct clinical differences between HLA-Cw*0602 positive and negative psoriasis patients--an analysis of 1019 HLA-C- and HLA-B-typed patients.

Authors:  Johann E Gudjonsson; Ari Karason; E Hjaltey Runarsdottir; Arna A Antonsdottir; Valdimar B Hauksson; Hjörtur H Jónsson; Jeff Gulcher; Kari Stefansson; Helgi Valdimarsson
Journal:  J Invest Dermatol       Date:  2006-04       Impact factor: 8.551

2.  Elevated prolactin levels in patients with rheumatoid arthritis: association with disease activity and structural damage.

Authors:  M Fojtíková; J Tomasová Studýnková; M Filková; Z Lacinová; J Gatterová; K Pavelka; J Vencovský; L Senolt
Journal:  Clin Exp Rheumatol       Date:  2011-01-03       Impact factor: 4.473

Review 3.  Polymorphisms of the human prolactin gene--implications for production of lymphocyte prolactin and systemic lupus erythematosus.

Authors:  A Stevens; D W Ray; J Worthington; J R Davis
Journal:  Lupus       Date:  2001       Impact factor: 2.911

4.  Clinical efficacy of propylthiouracil and its influence on prolactin in psoriatic patients.

Authors:  Hemamalini Malligarjunan; Pushpa Gnanaraj; Swapna Subramanian; Tamilselvi Elango; Haripriya Dayalan
Journal:  Clin Biochem       Date:  2011-07-28       Impact factor: 3.281

5.  Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis.

Authors:  R C Trembath; R L Clough; J L Rosbotham; A B Jones; R D Camp; A Frodsham; J Browne; R Barber; J Terwilliger; G M Lathrop; J N Barker
Journal:  Hum Mol Genet       Date:  1997-05       Impact factor: 6.150

6.  The human prolactin gene upstream promoter is regulated in lymphoid cells by activators of T-cells and by cAMP.

Authors:  G H Reem; D W Ray; J R Davis
Journal:  J Mol Endocrinol       Date:  1999-06       Impact factor: 5.098

7.  Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death.

Authors:  D D Gladman; V T Farewell; K Wong; J Husted
Journal:  Arthritis Rheum       Date:  1998-06

8.  Prolactin enhances production of interferon-gamma, interleukin-12, and interleukin-10, but not of tumor necrosis factor-alpha, in a stimulus-specific manner.

Authors:  Khalid Z Matalka
Journal:  Cytokine       Date:  2003-02-21       Impact factor: 3.861

9.  Hyperprolactinaemia in patients with systemic lupus erythematosus.

Authors:  L Moszkorzová; Z Lacinová; J Marek; L Musilová; A Dohnalová; C Dostál
Journal:  Clin Exp Rheumatol       Date:  2002 Nov-Dec       Impact factor: 4.473

10.  HLA-Cw6 and HLA-DRB1*07 together are associated with less severe joint disease in psoriatic arthritis.

Authors:  Pauline Y P C Ho; Anne Barton; Jane Worthington; Wendy Thomson; Alan J Silman; Ian N Bruce
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

View more
  3 in total

Review 1.  Interactions of the Immune System with Skin and Bone Tissue in Psoriatic Arthritis: A Comprehensive Review.

Authors:  Andrea Sukhov; Iannis E Adamopoulos; Emanual Maverakis
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

Review 2.  HLA-Cw1 and Psoriasis.

Authors:  Yi-Wei Huang; Tsen-Fang Tsai
Journal:  Am J Clin Dermatol       Date:  2021-01-18       Impact factor: 7.403

3.  Associations between human leukocyte antigen C locus polymorphism and psoriatic arthritis in populations of European and Middle Eastern descent: a meta-analysis.

Authors:  Lin-Nan Shao; Ni Wang; Shi-Hang Zhou; Zi Wang
Journal:  Ann Saudi Med       Date:  2020-08-06       Impact factor: 1.526

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.